您的位置:

cyclin E在肠型胃癌中的表达及意义

2022-07-29
来源:求医网
摘要目的:探讨cyclin E蛋白表达与肠型胃癌的临床病理特征及预后的关系。方法:以免疫组化法分析59例肠型胃癌的cyclin E蛋白表达情况。结果:正常胃粘膜上皮细胞呈阴性反应,而30例(30/59)肠型胃癌组织被免疫染色。cyclin E的异常表达与肿瘤的浸润深度显著相关,强阳性者5年生存率低。结论:cyclin E的异常表达与肠型胃癌的发展有关,并可作为一项预后指标。

中国图书资料分类法分类号R735.2

The role of cyclin E expression in the intestinal type gastric cancer

LI Jia-Qing, CAI Wen-Yan, ZHANG Zai-Xing

(Department of Surgery, the First Hospital, Beijing Medical University, Beijing100034)

MeSHcyclins/biosynStomach neoplasms/chemcyclin E

ABSTRACTObjective: To investigate the correlation of cyclin E expression with the clinicopathologic features and prognosis of intestinal type gastric cancer.Methods: The expression of cyclin E protein in 59 patients with intestinal type gastric cancer was studied by means of immunohistochemistry.Results: Normal gastric epithelial cells were negative, while 30(30/59) carcinomatous tissues were immunostained. Abnormal expression of cyclin E was significantly related to invasion depth of intestinal type gastric cancer. The patients with strongly positive expression of cyclin E tended to have a lower postoperative 5 year survival rate than other groups.Conclusion: Abnormal expression of cyclin E might take part in and promote the progression of intestinal type gastric cancer, and it might be used as a prognostic factor.

(J Beijing Med Univ, 1999,31:71-73)

人类细胞中,cyclin E、cyclin A、cyclin D是G1期细胞周期蛋白。cyclin E、细胞周期蛋白依赖激酶2(cyclin-dependent kinase 2,CDK2)共同在G1晚期调节G1期到S期的过渡。cyclin E结合并激活CDK2可直接促进G1/S期的转变。异常变化的cyclin E将使G1/S期过渡失调,有可能导致细胞的无限制增殖,而参与多种肿瘤的发生和发展[1]。文献报道cyclin E的异常表达能促进结、直肠癌的发生和进展[2],并与乳腺癌的发生相关[3]。本文探讨cyclin E在肠型胃癌中的表达及其与肠型胃癌预后之间的关系。

1材料与方法

取1987~1991年连续手术切除的肠型胃癌标本59例。其中男47例,女12例;年龄最大88岁,最小45岁。随访至1996年12月30日。标本经100 g.L-1福尔马林固定,石蜡包埋。每例标本都选择包括肿瘤中心和肿瘤边缘的石蜡块1~2个,制成连续切片后,进行免疫组化和HE染色。肠型胃癌的组织学类型包括乳头状腺癌、管状腺癌和粘液腺癌。

3 μm厚的切片按ABC法进行免疫组化染色[2],药盒为Histofine (Nichirei公司,日本)产品。组织切片经二甲苯脱蜡、水化后浸入0.088mol.L-1的H2O2中30 min,以阻断内源性氧化酶的活性。为充分暴露抗原,切片在0.01 mol.L-1、pH 6.5的柠檬酸缓冲液内加热到100℃,持续30min。经抗cyclin E单克隆抗体(Santa Cruz公司,体积比1∶600稀释)4℃孵育12 h后,室温下切片分别再与兔抗鼠血清反应20 min,PAP(peroxidase-anti-peroxidase)复合物反应15 min。随后H2O2-DAB显色2 min。经苏木精复染1 min,脱水、透明、封片。

每张切片选择5个不同的代表性区域(即切片的中心及上、下、左、右四边)分别进行细胞计数。每区计数200、5区共1 000个细胞,算出染色细胞所占比例。cyclin E的染色结果分为3级:阴性(-),染色细胞数<5%;阳性(+),染色细胞数5%~50%;强阳性(++),染色细胞数>50%{1]

统计学处理:cyclin E表达与预后的关系使用Kaplan-Meier分析中的Longrank法,与浸润深度、性别等的关系采用χ2检验,与年龄等的关系使用双侧t检验。

2结果

2.1正常和癌组织中cyclin E的表达

正常胃粘膜上皮细胞不被抗cyclin E单克隆抗体染色。各种血管内皮细胞浆都呈棕色反应,淋巴细胞浆轻度黄染,而两种细胞胞核均不染色(图1)。肠型胃癌组织中,棕色的免疫反应物位于细胞核内,且染色细胞分布不均匀(图2)。肠型胃癌总的染色阳性共有30例(30/50),其中(+)有18例(18/59),(++)有12例(12/59),表1。

图1正常胃粘膜cyclin E表达:腺上皮细胞不被染色,

部分淋巴细胞浆轻度黄染免疫组化染色×200

Figure 1Expression of cyclin E in normal gastric mucosa. None

of glandular epithelial cell was stained. The cytoplasm of some

lymphocytes was slightly stained brown

Immunohistochemical staining×200

图2肠型胃癌组织cyclin E表达:棕色免疫反应物位于

细胞核内,染色细胞所占比例≥5%免疫组化染色×200

Figure 2Expression of cyclin E in gastric cancerous tissue. The brown

immunoreactivities were localized in the nuclei of stained cells.

Stained cells were more than 5% of counted cells

Immunohistochemical staining×200

2.2cyclin E蛋白表达与临床病理特征的关系

cyclin E蛋白表达与患者年龄、肿瘤大小、位置、病理肉眼类型、组织学类型、间质量、淋巴结转移和腹膜转移无关。但与性别相关,男性患者表达增高;其表达强度与肿瘤的浸润深度也相关,浸润深者表达增高;另外,异常表达还与肠型胃癌的远处转移有关,强阳性表达患者的远处转移率显著增高,表1。

表1肠型胃癌中cyclin E的表达与临床病理特征的关系

Table 1The correlation of cyclin E expression

with clinicopathologic features in intestinal type gastric cancer

Clinicopathologic

features n cyclin E expression - + ++ TPR/% Sum 59 29 18 12 51 Sex Male 47 20 17 10 57 Female 12 9 1 2 25 Invasion depth Mucosa 12 9 3 0 25 Submucosa 14 4 8 2 71 Muscularis 9 3 3 3 67 Other* 24 13 4 7 46 Remote Negative 56 29 18 9 48 metastasis Positive 3 0 0 3 100

TPR,total positive rate; *,included subserosa, serosa and metastasis; sex,male vs female, P<0.05; invasion depth, mucosa vs submucosa, P<0.05; mucosa vs muscularis, P=0.059; mucosa vs other, P>0.05; submucosa vs muscularis, P>0.05; submucosa vs other, P<0.05; muscularis vs other, P>0.05; remote metastasis, negative vs positive, P<0.01.

2.3cyclin E蛋白表达与预后的关系

在全部肠型胃癌患者中强阳性表达者术后5年生存率显著降低。虽差异无统计学意义,但根治性切除患者中强阳性表达组的5年生存率仍然较低(表2)。

表2肠型胃癌中cyclin E表达与预后的关系

T